Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001949758 | SCV002203261 | benign | Kleefstra syndrome 1 | 2024-06-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004975904 | SCV005576864 | uncertain significance | Inborn genetic diseases | 2024-11-15 | criteria provided, single submitter | clinical testing | The c.2080G>A (p.E694K) alteration is located in exon 13 (coding exon 13) of the EHMT1 gene. This alteration results from a G to A substitution at nucleotide position 2080, causing the glutamic acid (E) at amino acid position 694 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |